Teleangiectasia macularis eruptiva perstansQ82.2

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 09.01.2024

Dieser Artikel auf Deutsch

Synonym(s)

Teleangiectasia eruptiva perstans; Teleangiectasia macularis eruptiva perstans; Urticaria pigmentosa adultorum

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Parkes Weber and Hellenschmied, 1930

DefinitionThis section has been translated automatically.

Clonal disease of the hematopoietic stem cell with the development of clinically heterogeneous clinical pictures characterized by mast cell accumulations in the skin and in internal organs.

In urticaria pigmentosa (cutaneous mastocytosis), the proliferation of mast cells is limited to the skin.

In systemic mastocytosis, at least 1 extracutaneous organ is affected.

Teleangiectasia eruptiva perstans is clinically characterized by the appearance of multiple telangiectasias rather than the characteristic pigmented patches/papules of maculopapular cutaneous mastocytosis.

EtiopathogenesisThis section has been translated automatically.

Most patients have an activating point mutation of the KIT gene (KIT D816V). However, both the expression of KIT (CD117) on the cell surface and the mutation are not specific for mastocytosis.

ManifestationThis section has been translated automatically.

V.a. occurring in adulthood. Occurrence in childhood is very rare and affects about 1% of childhood mastocytosis cases.

LocalizationThis section has been translated automatically.

Preference for the trunk, but extremities also possible Face remains unaffected. The face can also be affected (see pictures).

Clinical featuresThis section has been translated automatically.

Frequently discreet, less frequently massive clinical picture in which itching is the main symptom (see below Urticaria pigmentosa adultorum). In a symmetrical arrangement in disseminated sowing, 0.2-2.0 cm large, roundish, red or reddish-brown patches interspersed with telangiectasia, which acquire a urticarial character when rubbed vigorously(Darian's sign).

Older efflorescences can get a yellow-brown coloration.

One also sees clinical pictures in which the teleangiectatic aspect completely dominates.

HistologyThis section has been translated automatically.

In contrast to the juvenile form of Urticaria pigmentosa, the mast cell infiltrates in the dermis of the telangiectatic form are often only discrete. They can be completely overlooked in the HE section, so that the diagnosis is missed. Only in special staining (e.g. Giemsa; CD25) the mast cells can be visualized.

Cave! The biopsy specimen must not be squashed during collection, otherwise the mast cells lose their granules, which are important for staining!

TherapyThis section has been translated automatically.

Symptomatic; cosmetic treatment of individual telangiectasias with laser (argon, pulsed dye laser). Otherwise see below maculopapular cutaneous mastocytosis.

Progression/forecastThis section has been translated automatically.

Chronic course, no regression tendencies

Note(s)This section has been translated automatically.

In the current classification of mastocytoses (see Arber DA et al. 2016) this variant of adult Urticaria pigmentosa is not mentioned. Therefore, its entity is disputed. From a dermatological-diagnostic point of view, however, knowledge of this, often only discrete cutaneous mastocytosis is necessary to be able to initiate the necessary diagnostic measures in a targeted manner.

LiteratureThis section has been translated automatically.

  1. Arber DA et al (2016) The 2016 revision to the World Health Organization classification of myeloidneoplasms
    and acute leukemia. Blood 127:2391-405.
  2. Kalayciyan AK, Kotogyan A (2001) Telangiectasia macularis eruptiva perstans. J Eur Acad Dermatol Venereol 15: 263-264
  3. Parkes Weber F, Hellenschmied R (1930) Telangiectasia macularis eruptiva perstans. Br J Dermatol 42: 374-382
  4. Pascual JC et al (2003) Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma. J Cutan Med Surg 7: 399-402
  5. Suzuki K et al (2002) Telangiectasia macularis eruptiva perstans in polycythemia rubra vera. Eur J Dermatol 12: 201-203

Authors

Last updated on: 09.01.2024